By Colin Kellaher
XOMA Royalty's top finance executive, Thomas Burns, is leaving the biotechnology royalty aggregator to pursue other opportunities.
XOMA on Monday said Jeffrey Trigilio, who most recently served as chief financial and operating officer of Obsidian Therapeutics, will succeed Burns as chief financial officer of the Emeryville, Calif., company.
Burns, who joined XOMA in August 2006, has been senior vice president of finance and finance chief since March 2017.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
January 12, 2026 07:50 ET (12:50 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.